Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xanthones from Hypericum roeperanum

G Rath1, O Potterat, S Mavi

  • 1Institut de Pharmacognosie et Phytochimie, Université de Lausanne, Switzerland.

Phytochemistry
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrospun composite nanofiber-based transmucosal patch for anti-diabetic drug delivery.

Journal of materials chemistry. B·2020
Same author

Bilateral clavicular attachment of omohyoid muscle.

Morphologie : bulletin de l'Association des anatomistes·2017
Same author

SU-E-T-597: Influence of Smoothing Parameters on Dynamic IMRT Plan Quality and Deliverability.

Medical physics·2017
Same author

SU-E-T-587: Whole IMRT, Hybrid IMRT and 3D Conformal Plan a Dosimetric Comparison for Large Target.

Medical physics·2017
Same author

SU-E-T-268: Evaluation of Photoneutron Contamination in Elekta Synergy-S High-Energy Linear Accelerator and Indigenous Novel Solution: The AIIMS Experience.

Medical physics·2017
Same author

Adductor accessorius - an unusual supernumerary adductor muscle of thigh.

La Clinica terapeutica·2015
Same journal

Five undescribed compounds isolated from Gerbera delavayi with their anti-inflammatory activity.

Phytochemistry·2026
Same journal

Ingenane diterpenoids with anti-inflammatory activity from the whole plants of Euphorbia peplus.

Phytochemistry·2026
Same journal

Discovery of cytotoxic 1,4-benzodioxane oxyneolignan analogues from Glechoma longituba.

Phytochemistry·2026
Same journal

Cinnamolides A-G, seven previously undescribed phytoconstituents from the peels of Cinnamomum chago and their anti-inflammatory activity.

Phytochemistry·2026
Same journal

Antiviral amide derivatives from Uvaria siamensis.

Phytochemistry·2026
Same journal

COX-2 inhibitors from Laportea bulbifera: Structure-activity relationship, kinetic investigation, and molecular docking.

Phytochemistry·2026
See all related articles

Researchers isolated four novel xanthones from Hypericum roeperanum roots. Some compounds showed antifungal activity against Candida albicans, indicating potential therapeutic applications.

Area of Science:

  • Natural Product Chemistry
  • Phytochemistry
  • Medicinal Chemistry

Background:

  • Xanthones are a class of organic compounds found in nature, known for diverse biological activities.
  • Hypericum species are a rich source of bioactive secondary metabolites, including xanthones.

Purpose of the Study:

  • To isolate and characterize new xanthone derivatives from the roots of Hypericum roeperanum.
  • To evaluate the antifungal potential of the isolated xanthones.

Main Methods:

  • Isolation of compounds using chromatographic techniques.
  • Structure elucidation through comprehensive spectroscopic analyses (NMR, MS) and chemical derivatization.
  • Antifungal activity screening using standard microbiological assays.

Related Experiment Videos

Main Results:

  • Four new xanthones, 5-O-methyl-2-deprenylrheediaxanthone B, 5-O-methylisojacareubin, 5-O-demethylpaxanthonin, and roeperanone, were identified.
  • Six known xanthones were also isolated and characterized.
  • Several isolated xanthones demonstrated significant antifungal activity against Candida albicans.

Conclusions:

  • The roots of Hypericum roeperanum are a valuable source of structurally diverse xanthones.
  • The identified xanthones, particularly those showing antifungal activity, warrant further investigation for drug development.